Investors focused on the Medical space have likely heard of Zynerba Pharmaceuticals (ZYNE), but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer ...

In the latest trading session, Zynerba Pharmaceuticals (ZYNE) closed at $7.26, marking a -1.43% move from the previous day. This move was narrower than the S&P 500's daily loss of 1.79%. Elsewhere, ...

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most ...

*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces the ...

Zynerba Pharmaceuticals (ZYNE) closed at $4.18 in the latest trading session, marking a -1.88% move from the prior day. This change lagged the S&P 500's 3.25% gain on the day. At the same time, the ...

Zynerba Pharmaceuticals (NASDAQ: ZYNE) stock is up some 300%. ZYNE stock is up because Harmony is offering to buy the whole company. Which is very nice indeed for those holding a position in Zynerba ...

Sign up for the best picks from our travel, fashion and lifestyle writers. When it comes to footwear, the Duchess of Sussex, tends to be a fan of a vertiginous ...

Zynerba Pharmaceuticals (ZYNE) closed the most recent trading day at $7.44, moving -0.53% from the previous trading session. This move lagged the S&P 500's daily gain of 0.37%. At the same time, the ...

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...